Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23919263 | 0.92 | PGR (0.31) | PGR | |
| SCHEMBL23919264 | 0.90 | TDP1 (0.32) | PGRNPSR1 | |
| SCHEMBL23919261 | 0.89 | CYP1A1 (0.34) | ALOX5 | |
| SCHEMBL23919470 | 0.89 | PRKDC (0.31) | ALDH1A1HPGDSMN1; SMN2MEN1KMT2A | |
| SCHEMBL23919450 | 0.88 | ALDH1A1 (0.33) | ALDH1A1HPGDSMN1; SMN2MEN1KMT2A | |
| SCHEMBL17036268 | 0.84 | ALOX5 (0.40) | ALOX5 | |
| SCHEMBL12206523 | 0.84 | ALDH1A1 (0.34) | ALDH1A1HPGDSMN1; SMN2MEN1KMT2A | |
| SCHEMBL23919268 | 0.84 | ALDH1A1 (0.37) | ALDH1A1HPGDSMN1; SMN2MEN1KMT2A | |
| SCHEMBL17036317 | 0.84 | ALOX5 (0.39) | ALDH1A1HPGDSMN1; SMN2ALOX5PGR | |
| SCHEMBL23919259 | 0.83 | TDP1 (0.30) | MEN1KMT2APGRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | OLA1, TAS2R19, TMEM109 | ALDH1A1 541/4885HPGD 4701/4885SMN1; SMN2 2558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.